Success Metrics

Clinical Success Rate
100.0%

Based on 15 completed trials

Completion Rate
100%(15/15)
Active Trials
2(9%)
Results Posted
53%(8 trials)

Phase Distribution

Ph not_applicable
1
4%
Ph phase_3
1
4%
Ph phase_4
7
30%
Ph phase_2
9
39%
Ph phase_1
5
22%

Phase Distribution

5

Early Stage

9

Mid Stage

8

Late Stage

Phase Distribution23 total trials
Phase 1Safety & dosage
5(21.7%)
Phase 2Efficacy & side effects
9(39.1%)
Phase 3Large-scale testing
1(4.3%)
Phase 4Post-market surveillance
7(30.4%)
N/ANon-phased studies
1(4.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

93.8%

15 of 16 finished

Non-Completion Rate

6.3%

1 ended early

Currently Active

2

trials recruiting

Total Trials

23

all time

Status Distribution
Active(3)
Completed(15)
Terminated(1)
Other(4)

Detailed Status

Completed15
unknown4
Enrolling by invitation1
Withdrawn1
Active, not recruiting1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
23
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 15 (21.7%)
Phase 29 (39.1%)
Phase 31 (4.3%)
Phase 47 (30.4%)
N/A1 (4.3%)

Trials by Status

unknown417%
completed1565%
enrolling_by_invitation14%
withdrawn14%
active_not_recruiting14%
recruiting14%

Recent Activity

Clinical Trials (23)

Showing 20 of 23 trialsScroll for more
NCT03753555Phase 4

The Effect of InTensive Statin in Ischemic Stroke With inTracranial Atherosclerotic Plaques

Recruiting
NCT04767984Phase 2

Testing Atorvastatin to Lower Colon Cancer Risk in Longstanding Ulcerative Colitis

Active Not Recruiting
NCT05826912Phase 2

Multi-Arm Multi-Stage Adaptive Platform Trial (APT) for the Acute Treatment of Traumatic Brain Injury

Enrolling By Invitation
NCT06081166Phase 1

A Drug-drug Interaction Study Evaluating the PK Effects of Obicetrapib on Atorvastatin and Rosuvastatin

Completed
NCT01555632Not Applicable

Atorvastatin Calcium in Preventing Metabolic Syndrome in Prostate Cancer Patients Receiving Androgen-Deprivation Therapy

Withdrawn
NCT00701220Phase 4

Statin Therapy for Ischemic and Nonischemic Cardiomyopathy

Completed
NCT01665677Phase 2

Atorvastatin as GVHD Prophylaxis for Allogeneic Hematopoietic Cell Transplantation

Completed
NCT05583643Phase 1

Clinical & Biochemical Effect of Atorvastatin in Nano Particles Gel in Periodontitis Treatment

Completed
NCT00000941Phase 1

A Study on Possible Interactions Between Protease Inhibitors (Anti-HIV Drugs) and Drugs Which Lower the Level of Fat in Your Blood

Completed
NCT04661709Phase 4

Efficacy and Safety of Wen Xin Granules for the Treatment of Unstable Angina Pectoris

Unknown
NCT01527045Phase 2

Donor Atorvastatin Treatment in Preventing Severe Acute GVHD After Nonmyeloablative Peripheral Blood Stem Cell Transplant in Patients With Hematological Malignancies

Completed
NCT03532620Phase 4

China Protection Trial of Glucose Metabolism by Pitavastatin in Patients With Prediabetes and Hypertension

Unknown
NCT00687271Phase 2

A Study of MK-6213 Co-Administered With Atorvastatin in Participants With Hypercholesterolemia (MK-6213-006)

Completed
NCT01050348Phase 4

To Investigate the Role of Upstream High Dose Statin in STEMI

Completed
NCT01220973Phase 2

Atorvastatin Calcium and Celecoxib in Treating Patients With Rising PSA Levels After Local Therapy for Prostate Cancer

Completed
NCT01525407Phase 2

Donor Atorvastatin Treatment for Preventing Severe Acute Graft-Versus-Host Disease in Patients Undergoing Myeloablative Peripheral Blood Stem Cell Transplantation

Completed
NCT03072082Phase 4

Curative Effect Evaluation of Danlou Tablet on Coronary Artery Disease Not Amenable to Revascularization

Unknown
NCT03072121Phase 4

Curative Effect Evaluation of Shexiang Baoxin Pill on Coronary Artery Disease Not Amenable to Revascularization

Unknown
NCT00335504Phase 2

Atorvastatin Calcium, Oligofructose-Enriched Inulin, or Sulindac in Preventing Cancer in Patients at Increased Risk of Developing Colorectal Neoplasia

Completed
NCT00637481Phase 1

A Phase I Prevention Study of Atorvastatin in Women at Increased Risk for Breast Cancer

Completed

Drug Details

Intervention Type
DRUG
Total Trials
23